Ulf Göran Richenberg
Vorsitzender bei KCIF Fund Management AB
Ursprung des Netzwerks ersten Grades von Ulf Göran Richenberg
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Financial Conglomerates | 41 | |
Vattenfall AB
 Vattenfall AB Electric UtilitiesUtilities Vattenfall AB engages in the generation, distribution, and sale of heat and electricity. It operates through the following segments: Heat, Customers and Solutions, Wind, Power Generation, and Distribution. The company was founded in 1909 and is headquartered in Solna, Sweden.
4
| Subsidiary | Electric Utilities | 4 |
KD Incentive AB
3
| Subsidiary | 3 | |
KCIF Fund Management AB
3
| Subsidiary | 3 | |
Esselte AB
 Esselte AB Office Equipment/SuppliesProducer Manufacturing Esselte AB manufactures office solutions. It sells office products and graphics products. The company was founded on April 18, 1913 and is headquartered in Solna, Sweden.
2
| Subsidiary | Office Equipment/Supplies | 2 |
AB Stokab
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ulf Göran Richenberg
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| TIANJIN BINHAI TEDA LOGISTICS (GROUP) CORPORATION LIMITED | Air Freight/Couriers | Director/Board Member Director/Board Member | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SINO BIOPHARMACEUTICAL LIMITED | Pharmaceuticals: Major | Founder Chairman | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| OREXO AB | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
Beijing Tide Pharmaceutical Co., Ltd.
 Beijing Tide Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Tide Pharmaceutical Co., Ltd. engages in research, development, manufacturing and sale of pharmaceutical products. The firm's products include kaifen flurbiprofen axetil injection, kaishi alprostadil injection, kaina beraprost sodium tablet and deyou pronase granules. The company was founded in May 1995 and is headquartered in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Private Equity Investor Chief Executive Officer Chairman Private Equity Investor Chief Executive Officer Chief Executive Officer Director of Finance/CFO Chief Executive Officer Chief Executive Officer Chief Executive Officer Private Equity Investor Director of Finance/CFO Private Equity Analyst | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree | |
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Gothenburg | College/University | Graduate Degree Graduate Degree | |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer Chairman | |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Director/Board Member Chief Executive Officer | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| PROMIMIC AB | Medical Specialties | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| BIOARCTIC AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member | |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Caerus Consulting AS
 Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal Chairman | |
ClanoTech AB
 ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member Chairman | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | Director/Board Member Director/Board Member | ||
| SYNACT PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Arctic Asset Management AS (Sweden)
 Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients. | Investment Managers | Founder Chief Executive Officer Analyst-Equity | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Founder | |
Sino Biopharmaceutical (Beijing) Ltd.
 Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistik
International
| Schweden | 39 |
| China | 5 |
| Dänemark | 3 |
| Norwegen | 3 |
| Cayman Islands | 2 |
Sektoral
| Health Technology | 29 |
| Commercial Services | 9 |
| Consumer Services | 7 |
| Finance | 5 |
| Transportation | 2 |
Operativ
| Director/Board Member | 437 |
| Chairman | 133 |
| Corporate Officer/Principal | 111 |
| Independent Dir/Board Member | 69 |
| Chief Executive Officer | 52 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Ping Tse | 43 |
| Viktor Drvota | 41 |
| Peter Sjöstrand | 35 |
| Bo Jesper Hansen | 34 |
| Stig Lennart Hansson | 32 |
| Michael Wilhelm Rosenlew | 32 |
| Khalid Islam | 29 |
| Torbjørn Bjerke | 27 |
| Michael Owens | 25 |
| Karl Härfstrand | 23 |
| Jim van Heusden | 22 |
| Gunilla Anders Ekström | 22 |
| Carl Johan Bertil Sundberg | 21 |
| Ewa Björling | 21 |
- Börse
- Insiders
- Ulf Göran Richenberg
- Unternehmensverbindungen
